Ticker Details
MEI Pharma, Inc. MEI Pharma Inc is an oncology company focused on the clinical development of novel therapeutics for cancer. The Company's portfolio of drug candidates includes Pracinostat, an oral histone deacetylase inhibitor.
IPO Date:	January 1, 2004
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$100.81M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.10 | 3.12%
Avg Daily Range (30 D):	$0.19 | 6.62%
Avg Daily Range (90 D):	$0.19 | 6.62%

Institutional Daily Volume
Avg Daily Volume:	.11M
Avg Daily Volume (30 D):	M
Avg Daily Volume (90 D):	M

Trade Size
Avg Trade Size (Sh.):	58
Avg Trade Size (Sh.) (30 D):	180
Avg Trade Size (Sh.) (90 D):	180

Institutional Trades
Total Institutional Trades:	133
Avg Institutional Trade:	$1.54M
Avg Institutional Trade (30 D):	$.71M
Avg Institutional Trade (90 D):	$.71M
Avg Institutional Trade Volume:	.03M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.3M
Avg Closing Trade (30 D):	$.56M
Avg Closing Trade (90 D):	$.56M
Avg Closing Volume:	50.8K

News

Jul 21, 2025 @ 7:29 PM Why Litecoin Soared Over the Weekend Source: Johnny Rice

May 2, 2025 @ 8:00 PM A new MEI study highlights the importance of micro... Source: Mei

Dec 24, 2024 @ 12:00 PM Liquid Mushroom Market is Expected to Rise at CAGR... Source: Fact.Mr

Jul 22, 2024 @ 6:44 PM MEI Pharma (NASDAQ:MEIP) Stock Quotes, Forecast an... Source: Benzinga

May 7, 2024 @ 9:50 PM Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Lags... Source: Zacks Equity Research

Financials
	TTM	FY 2025	Q3 2025
Basic EPS	$-.4	$-2.39	$-.39
Diluted EPS	$-.4	$-2.39	$-.39
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-2.69M	$-15.95M	$-2.57M
Operating Income / Loss	$-2.88M	$-17.46M	$-2.77M
Cost of Revenue
Net Cash Flow	$M	$M	$M
PE Ratio

Splits
Apr 17, 2023	1:20
Dec 19, 2012	1:6
Mar 31, 2010	1:10